Abstract
Osteoarthritis of knee joints is a disease of old age in both sex. It is very common after the age of 40 years in elderly females or in postmenopausal phase of females. It is characterized by narrowing of space in joints due to inflammation. The exact mechanism of inflammation in this disease is not yet clear. Tumor necrosis factor alpha (TNF-α) may involve in onset of disease. The present study is being carried out in 130 female subject of age group 40–60 years suffering from osteoarthritis of knee joints and 50 normal healthy control female subjects. A correlation is made between TNF-α and estrogen and found significant inverse correlation (r<0.001), between TNF-α and estrogen hormone in osteoarthritic female patients as compared to normal healthy control female group.
Similar content being viewed by others
Bibliography
Moheu, E., Dreiser, R.L., Guillou, G.B. and Dewailly, J. (2000). Hand osteoarthritis patients characteristics according to the existence of hormone replacement therapy. Osteoarthritis cartilage. 8 (suppl. A), 533–537.
Vonmuhlen, D., Morton, D., Vonmuhlen, C.A. and Barrett-conmore, E. (2002). Postmenopausal estrogen and increased risk of clinical osteoarthritis at the hip, hand, and knee in older women. Journal of women health. 6, 511–518.
Masahiko, Kobayashi, Ginette, R., Squires, Aisha, Mousa, Michael Tanzer, Davidm, J., Zukor, John Antoniou, Ulrich, Feique A., Robin, Poole (2005). Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis and Rheumatism. 52, 128–135.
Sunyer, Tersa, Lewis, Jennifer, Collinosdoby, Patricia and Osdoby, Philip (1999). Estrogen bone protective effects may involve differential IL-1 receptors regulation in human osteoclast cell. Journal of clinical investigation 103 (10), 1409–1420.
Rogers A. and Eqstell, R. (1998). Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. Journal of Bone Mineral Research 13 (10), 1577–1586.
Iannone, F. and Lapadula, G. (2003). The pathophysiology of osteoaerthritis. Aging Clinical Experimental Research 15 (5), 364–372.
Piere, Pelletier, Robert, Mccollum, Jean, Mariecloutier and Jhanne, Martelpelletier (1995). Synthesis of metalloproteases and interleukin-6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process. Journal of Rheumatology. 22, 109–114.
Fernandes, J.C., Martel-pelletier, J. and Pelletier, J.P. (2002). The role of cytokines in osteoarthritis pathophysiology. Biorheology 39 (12), 237–246.
Tetlow, L.C., Adlam, D.J. and Woolley, D.E. (2001). Matrix. Metalloproteinase and proinflammatory cytokine production by osteoarthritic of human osteoarthritic cartilage: association with degenerative changes. Arthritis and Rheumatism 44 (3), 589–594.
Lee, Y.J., Lee, E.B., Kwon, Y.E., Lee, J.J., Cho, W.S., Kim, H.A. and Song, Y.W. (2003). Effect of estrogen on the expression of matrix mettaloproteinase (MMP)-1, MMP-3 and tissue inhibitor of mettaloproteinase-1 in osteoarthritis chondrocytes. Rheumatology Int. 23 (6), 282–288.
Parazini, F. (2003). Menopausal status hormone replacement therapy use and risk of self reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy. Maturitas 46 (3), 207–212.
Janecauley, A., Kentkwoh, C., Graceegeland, Michael Nevittc, Lawrence, Cooperstein, Jiffrey Rohay, Adele Towers and Jamesgutai, P. (1993). Serum sex hormones and severity of osteoarthritis of the hand. Journal of Rheumatology. 20, 1170–1175.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharma, P., Singh, N., Singh, V. et al. Tumor necrosis factor alpha (TNF-α) and estrogen hormone in osteoarthritic female patients. Indian J Clin Biochem 21, 205–207 (2006). https://doi.org/10.1007/BF02913099
Issue Date:
DOI: https://doi.org/10.1007/BF02913099